Find your next paid study

Rockefeller UniversityNCT05709483

~$500 – $7,500

Actual pay is set by the research site.

CIPN - Chemotherapy-Induced Peripheral NeuropathyPain

Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy: A Randomized Phase II Pilot Trial.

The investigators hypothesize that Scrambler therapy with duloxetine, compared to duloxetine-based usual care, will result in greater improvement in CIPN as me…

Fox Chase Cancer CenterNCT06914557

~$75 – $2,000

Actual pay is set by the research site.

Platinum-resistant Ovarian Cancer

A Phase 2, Open-label, Single-arm Study Of Autologous Memory Cytokine Enriched Natural Killer (M-CENK) Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

This is phase 2 single arm study evaluating the safety and preliminary efficacy of M-CENK adoptive cell therapy and fixed dose of N-803 in combination with gem…

ImmunityBio, Inc.NCT06710288

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Selected Advanced or Metastatic Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of BGB-B203…

Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more

~$150 – $4,500

Actual pay is set by the research site.

BeOne Medicines

Heart TransplantHeart FailureTransplant; Failure, Heart

PRESERVE CAP: A Prospective, Multi-Center, Single-Arm, Open-Label Study of Hearts Transplanted After Non-Ischemic Heart Preservation From Extended Donors Continued Access Protocol

The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System …

XVIVO PerfusionNCT06895070

~$10 – $1,125

Actual pay is set by the research site.

Bladder CancerUrothelial CarcinomaUpper Tract Urothelial Carcinoma+1 more

The "Get Moving Trial": A Phase I/II RCT of Home-Based (P)Rehabilitation With ExerciseRx in Bladder Cancer and Upper Tract Urothelial Cancer

Prehabilitation refers to the process of improving a patient's functional capabilities prior to a surgical procedure with the goal of decreasing post-surgical …

University of WashingtonNCT06040762

~$10 – $750

Actual pay is set by the research site.

Phase 1

A Phase Ib Investigation of the LSD1 Inhibitor Iadademstat (ORY-1001) in Combination With Azacitidine and Venetoclax in Newly Diagnosed AML

This phase I trial tests the safety, side effects, and best dose of iadademstat when given together with azacitidine and venetoclax in treating patients with n…

Acute Myeloid LeukemiaMyelodysplastic Syndrome/Acute Myeloid Leukemia

OHSU Knight Cancer InstituteNCT06357182

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

Application of a 5% Lidocaine Ointment to Endotracheal Tubes to Reduce Emergence Bucking: a Randomized Double-Blind Prospective Trial.

This prospective, randomized, double-blind, two-arm clinical trial will evaluate whether applying 5% lidocaine ointment to endotracheal tubes before intubation…

Emergency Coughing

Ohio State UniversityNCT07709390

~$150 – $3,000

Actual pay is set by the research site.

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

The purpose of this study is to determine if experimental drug treatment improves recovery after TBI as compared to a control (placebo) group. Changes in recov…

Traumatic Brain Injury

University of California, San FranciscoNCT05826912

~$75 – $1,800

Actual pay is set by the research site.

Type 1 DiabetesT1D Heart FailureCardio-renal Vascular Function and Failure+1 more

Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications in People With T1D (Precision T1D Platform)

Breakthrough T1D has awarded support for a joint University of Michigan-Oregon Health \& Science University Center of Excellence (CoE) to address cardio-renal …

Oregon Health and Science UniversityNCT07594145

~$75 – $2,000

Actual pay is set by the research site.

Spinal Cord InjuriesDepressionDepressive Disorder, Major

Evaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury

Depression is a leading cause of disability worldwide and is more commonly seen in individual's post-spinal cord injury (SCI) than in the general population. D…

VA Office of Research and DevelopmentNCT05553353

~$10 – $675

Actual pay is set by the research site.

Otitis Media With Effusion (OME)Eustachian Tube DysfunctionOtitis Media With Effusion

EarFlo: A Non-Invasive Treatment for Otitis Media With Effusion & Eustachian Tube Dysfunction in Adults

This study evaluates the use of the EarFlo device in adults with clinically confirmed Eustachian tube dysfunction and/or otitis media with effusion. The purpos…